4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: May 7, 2015
Period of Report: March 23, 2015
Accession Number: 0001144204-15-028484

View Document ↗ View on SEC.gov ↗